Bayan Matarneh

Dr. Bayan Matarneh

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
BMBayan Matarneh
Bayan Matarneh
PWPatricia Witman
Patricia Witman

30 November 2021 in Pediatric Dermatology
Verified
Journal Article
Open access
PDF file
BMBayan Matarneh
Bayan Matarneh
EFEsteban Fernandez Faith
Esteban Fernandez Faith
Click on the article title to read more.

17 November 2025
Verified
Preprint
Open access
AMAhmad Matarneh
Ahmad Matarneh
BMBayan Matarneh
Bayan Matarneh
OSOmar Salameh
Omar Salameh
SSSundus Sardar
Sundus Sardar
CACatherine Abendroth
Catherine Abendroth
NVNavin Verma
Navin Verma

7 January 2026 in Case Reports in Pediatrics
Verified
Journal Article
Open access
BMBayan Matarneh
Bayan Matarneh
RJRichard Johnson
Richard Johnson
JBJamie Bell
Jamie Bell
Infants with severe hyponatremia (Na < 120) and an abdominal mass require an astute clinical evaluation and often represent a medical emergency. We report a case of a 2‐month‐old White female, born full term, presenting with a two‐day history of decreased oral intake and urinary output, who was found to have severe hyponatremia with notable abdominal distention. Abdominal imaging revealed the presence of a pelvic mass causing obstructive uropathy. Further imaging and urogenital examination revealed a hydrometrocolpos. This rare entity required urgent surgical intervention and standard supportive care in the PICU. She had a subsequent significant improvement in symptoms and prevention of further deleterious complications.

22 January 2026 in Medicina
Verified
Journal Article
Open access
PDF file
AMAhmad Matarneh
Ahmad Matarneh
BMBayan Matarneh
Bayan Matarneh
AAAbdelrauof Akkari
Abdelrauof Akkari
SSSundus Sardar
Sundus Sardar
OSOmar Salameh
Omar Salameh
NGNasrollah Ghahramani
Nasrollah Ghahramani
Background and Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is a leading cause of end-stage renal disease (ESRD). Progressive renal cyst growth in ADPKD can exert mass effects, including compression of the inferior vena cava (IVC), a rare but clinically significant complication with implications for hemodynamic stability and renal outcomes. This study evaluated the prevalence of IVC compression in ADPKD and its impact on progression to ESRD, mortality, and overall survival. We aimed to provide quantitative measures to elucidate its prognostic significance. Materials and Methods: Using the TriNetX database, we conducted a retrospective cohort study of 658 ADPKD patients with IVC compression, comparing them to unmatched controls without compression. Outcomes included ESRD incidence, mortality, and survival. Kaplan–Meier curves and hazard ratios (HRs) with 95% confidence intervals (CIs) were used for analysis. Results: ESRD Risk: IVC compression was associated with a higher risk of ESRD (77.4% vs. 29.7%, RR: 2.61, 95% CI: 2.49–2.73, p < 0.001). Survival Probability: 5-year Survival was significantly reduced in patients with IVC compression (42.6%) compared to controls (61.7%) (HR: 4.00, 95% CI: 3.45–4.63, p = 0.002). Mortality: Mortality was higher in the compression group (29.2% vs. 9.1%). Combined Impact: ESRD patients with IVC compression had a lower survival rate (11.9%) than ESRD patients without compression (28.5%) (HR: 5.60, 95% CI: 5.12–6.13, p < 0.001). Conclusions: IVC compression in ADPKD is associated with significantly worse outcomes, including increased ESRD risk, higher mortality, and reduced survival. These findings underscore the importance of early diagnosis and targeted management strategies.

17 September 2025
Verified
Preprint
Open access
AMAhmad Matarneh
Ahmad Matarneh
OSOmar Salameh
Omar Salameh
BMBayan Matarneh
Bayan Matarneh
MRMiran Rhee
Miran Rhee
NGNasrollah Ghahramani
Nasrollah Ghahramani
NTNaman Trivedi
Naman Trivedi